Literature DB >> 16954559

Noninvasive imaging of atherosclerotic lesions in apolipoprotein E-deficient and low-density-lipoprotein receptor-deficient mice with annexin A5.

Satoshi Isobe1, Sotirios Tsimikas, Jun Zhou, Shinichiro Fujimoto, Masayoshi Sarai, Michael J Branks, Ai Fujimoto, Leonard Hofstra, Chris P Reutelingsperger, Toyoaki Murohara, Renu Virmani, Frank D Kolodgie, Navneet Narula, Artiom Petrov, Jagat Narula.   

Abstract

UNLABELLED: Transgenic mice such as apolipoprotein E-deficient (apoE(-/-)) and low-density-lipoprotein receptor-deficient (LDLR(-/-)) mice exhibit hypercholesterolemia and develop complex atherosclerotic lesions similar to those seen in humans. Radiolabeled annexin A5 has been successfully used to noninvasively image experimental and clinical atherosclerotic disease. We evaluated the feasibility of annexin A5 imaging in transgenic apoE(-/-) and LDLR(-/-) mice with or without a cholesterol diet.
METHODS: Thirty-three mice (mean age, 62 +/- 0.9 wk old) were used. Of these 33 mice, apoE(-/-) mice with the cholesterol diet for 4 mo (n = 5) and without the cholesterol diet (n = 8) and LDLR(-/-) mice with the cholesterol diet for 6 mo (n = 7) and without the cholesterol diet (n = 7) were compared with 6 normal wild-type (C57BL/6) mice with the same genetic background. (99m)Tc-annexin A5 was injected in 31 animals for noninvasive imaging using micro-SPECT/CT. After in vivo micro-SPECT/CT, aortas were explanted to acquire ex vivo images and calculate the percentage injected dose per gram (%ID/g) annexin uptake, followed by histologic and immunohistochemical characterization. For the evaluation of precise target localization, biotinylated annexin A5 was injected in the remaining 2 normally fed apoE(-/-) mice.
RESULTS: Aortic lesions were clearly visualized noninvasively by micro-SPECT and aorta calcification was detectable by micro-CT. The quantitative uptake of annexin A5 was highest in the cholesterol-fed apoE(-/-) (0.88 +/- 0.27 %ID/g) mice, followed by the normal chow-fed apoE(-/-) (0.60 +/- 0.16 %ID/g), the cholesterol-fed LDLR(-/-) (0.59 +/- 0.14 %ID/g), the chow-fed LDLR(-/-) (0.40 +/- 0.31 %ID/g), and the control (0.15 +/- 0.05 %ID/g) mice. The histologic extent of atherosclerosis paralleled radiotracer uptake, and immunohistochemical studies revealed a significant correlation between radiotracer uptake and both macrophage infiltration and the extent of apoptosis. Intravenously injected biotinylated annexin A5 localized in apoptotic and nonapoptotic macrophages.
CONCLUSION: This study demonstrates the feasibility of noninvasive imaging of atherosclerosis with radiolabeled annexin A5 in transgenic mouse models of human atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16954559

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  33 in total

1.  (18)F-fluorodeoxyglucose PET imaging of coronary atherosclerosis and plaque inflammation.

Authors:  Wengen Chen; Vasken Dilsizian
Journal:  Curr Cardiol Rep       Date:  2010-03       Impact factor: 2.931

Review 2.  "Eat me" imaging and therapy.

Authors:  Vaishali Bagalkot; Jeffrey A Deiuliis; Sanjay Rajagopalan; Andrei Maiseyeu
Journal:  Adv Drug Deliv Rev       Date:  2016-01-27       Impact factor: 15.470

Review 3.  Imaging atherosclerosis in the vulnerable patient.

Authors:  Giovanni Lucignani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-01       Impact factor: 9.236

Review 4.  Noninvasive imaging of apoptosis in cardiovascular disease.

Authors:  Ethan Chauncey Korngold; Farouc Amin Jaffer; Ralph Weissleder; David Edwin Sosnovik
Journal:  Heart Fail Rev       Date:  2008-06       Impact factor: 4.214

Review 5.  Imaging outcomes in cardiovascular clinical trials.

Authors:  Louai Razzouk; Michael E Farkouh
Journal:  Nat Rev Cardiol       Date:  2009-06-30       Impact factor: 32.419

6.  Who gets the heart attack: noninvasive imaging markers of plaque instability.

Authors:  Jagat Narula
Journal:  J Nucl Cardiol       Date:  2009 Nov-Dec       Impact factor: 5.952

7.  Noninvasive Positron Emission Tomography Imaging of Coronary Arterial Inflammation.

Authors:  Amr Abdelbaky; Ahmed Tawakol
Journal:  Curr Cardiovasc Imaging Rep       Date:  2011-02-01

8.  Dual molecular imaging for targeting metalloproteinase activity and apoptosis in atherosclerosis: molecular imaging facilitates understanding of pathogenesis.

Authors:  Nezam Haider; Dagmar Hartung; Shinichiro Fujimoto; Artiom Petrov; Frank D Kolodgie; Renu Virmani; Satoru Ohshima; Han Liu; Jun Zhou; Ai Fujimoto; Atsuko Tahara; Leo Hofstra; Navneet Narula; Chris Reutelingsperger; Jagat Narula
Journal:  J Nucl Cardiol       Date:  2009-08-07       Impact factor: 5.952

Review 9.  Phosphatidylserine targeting for diagnosis and treatment of human diseases.

Authors:  Kristof Schutters; Chris Reutelingsperger
Journal:  Apoptosis       Date:  2010-09       Impact factor: 4.677

Review 10.  Small-animal SPECT and SPECT/CT: application in cardiovascular research.

Authors:  Reza Golestani; Chao Wu; René A Tio; Clark J Zeebregts; Artiom D Petrov; Freek J Beekman; Rudi A J O Dierckx; Hendrikus H Boersma; Riemer H J A Slart
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-01-13       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.